Solid Tumors

• CLINICAL_TRIALS research · 2025-03-05
  Clinical Trial Update: A Trial of SHR-4849 in Advanced Solid Tumors [Phase 1]

  Clinical trial update for SHR-4849 in advanced solid tumors describing a Phase 1 study that is currently recruiting.

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma [Phase 1]

  First-in-human Phase 1 study of EMB-07 in patients with advanced/metastatic solid tumors or relapsed/refractory lymphoma is currently recrui…

• CLINICAL_TRIALS research · 2025-02-26
  Clinical Trial Update: APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid Tumors [Phase 1, Phase 2]

  Clinical trial update describing an ongoing Phase 1/2 study of APG-115 in combination with a PD-1 inhibitor for patients with liposarcoma or…

• CLINICAL_TRIALS research · 2025-02-26
  Clinical Trial Update: APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST [Phase 1]

  Phase 1 trial of APG-2449 as monotherapy or with pegylated liposomal doxorubicin (PLD) in platinum-resistant recurrent ovarian cancer and ad…

• CLINICAL_TRIALS research · 2025-02-24
  Clinical Trial Update: TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies [Phase 1]

  A Phase 1 study of TGRX-1942 for advanced solid tumors and/or relapsed/refractory hematologic malignancies is currently recruiting in China.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-02-19
  Clinical Trial Update: Safety Study of Sterile Compound C31510 for Injection to Subjects With Solid Tumors [Phase 1]

  This report provides an update on a Phase 1 safety study of sterile compound C31510 for injection in subjects with solid tumors. The trial h…

• CLINICAL_TRIALS trial_result · 2025-02-19
  Clinical Trial Update: BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors [Phase 1]

  A Phase 1 trial of BP31510 Ubidecarenone nanosuspension for intravenous injection in solid tumors has completed, according to the update. Th…

• CLINICAL_TRIALS trial_result · 2025-02-11
  Clinical Trial Update: Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer [Phase 1]

  The document reports completion of a Phase 1 trial evaluating selumetinib in combination with cyclosporine for advanced solid tumors or adva…

• CLINICAL_TRIALS trial_result · 2025-02-10
  Clinical Trial Update: Evaluation of SAR408701 in Patients With Advanced Solid Tumors [Phase 1]

  This Phase 1 trial evaluated SAR408701 in patients with advanced solid tumors. The study status is terminated.

• CLINICAL_TRIALS research · 2025-02-07
  Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors [Phase 1]

  A Phase 1 clinical trial is evaluating CD-001 to assess safety, tolerability, pharmacokinetics, and preliminary efficacy in adults with adva…

• CLINICAL_TRIALS research · 2025-02-06
  Clinical Trial Update: Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors [EARLY_Phase 1]

  A Phase 1 clinical trial is evaluating intravenous IDOV-SAFETM in patients with advanced solid tumors and is currently recruiting to assess …

• CLINICAL_TRIALS trial_result · 2025-02-04
  Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies [Phase 1]

  A Phase 1 trial evaluating the safety and tolerability of AB154 in adults with advanced solid tumors has completed.

• CLINICAL_TRIALS research · 2025-02-04
  Clinical Trial Update: Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors [EARLY_Phase 1]

  Clinical trial update describing a Phase 1 study of Intravenous IDOV-SAFETM in patients with advanced solid tumors, currently recruiting.

• CLINICAL_TRIALS research · 2025-01-30
  Clinical Trial Update: A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer [Phase 1]

  Phase 1 study evaluating BTX-A51 in patients with advanced solid tumors and metastatic breast cancer; recruitment is ongoing.

• CLINICAL_TRIALS trial_result · 2025-01-30
  Clinical Trial Update: First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors [Phase 1]

  Phase 1 first-in-human trial update reports on the safety and tolerability of MP0317 in patients with relapsed/refractory advanced solid tum…

• CLINICAL_TRIALS trial_result · 2025-01-29
  Clinical Trial Update: Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies [Phase 1]

  Phase 1 study evaluating the safety and tolerability of RXC004 in patients with advanced malignancies; results have been posted.

• CLINICAL_TRIALS trial_result · 2025-01-29
  Clinical Trial Update: A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations [Phase 1]

  A Phase 1 study evaluating KNT-0916 in unresectable or metastatic solid tumors with FGFR2 alterations. The trial status is not yet recruitin…

• CLINICAL_TRIALS trial_result · 2025-01-28
  Clinical Trial Update: A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors [EARLY_Phase 1]

  A microdose Phase 1 study of the radiopharmaceutical TTX-MC138-NODAGA-Cu64 in patients with advanced solid tumors has completed. The sponsor…

• CLINICAL_TRIALS trial_result · 2025-01-28
  Clinical Trial Update: A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors [Phase 1]

  Phase 1 study of ADA-011 for advanced solid tumors has been terminated.

• CLINICAL_TRIALS trial_result · 2025-01-27
  Clinical Trial Update: Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors [Phase 1]

  Phase 1 clinical trial evaluating safety and preliminary activity of KT-253 in adults with high-grade myeloid malignancies, acute lymphoblas…

• CLINICAL_TRIALS trial_result · 2025-01-24
  Clinical Trial Update: PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy [Phase 2]

  Phase 2 trial evaluating palmitoylethanolamide (PEA) for relief of chemotherapy-induced peripheral neuropathy; study is active-not-recruitin…

• CLINICAL_TRIALS trial_result · 2025-01-22
  Clinical Trial Update: A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors [Phase 1]

  Phase 1 study results assess the clinical and immunologic effects of ALT-803 in patients with advanced solid tumors.

• CLINICAL_TRIALS trial_result · 2025-01-22
  Clinical Trial Update: Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors [Phase 1, Phase 2]

  Clinical trial update on ASN-3186 for patients with advanced solid tumors in Phase 1/2, sponsored by Jiangsu Yahong Meditech Co., Ltd (Asier…

• CLINICAL_TRIALS research · 2025-01-22
  Clinical Trial Update: A Study of SHR-4375 in Subjects With Solid Tumors [Phase 1, Phase 2]

  A clinical trial update indicates that SHR-4375 is being studied in Phase 1/2 for patients with solid tumors, with recruitment ongoing.

• CLINICAL_TRIALS research · 2025-01-17
  Clinical Trial Update: AMT-116 in Patients with Solid Tumors [Phase 1, Phase 2]

  This is a Phase 1/2 clinical trial evaluating AMT-116 in patients with advanced solid tumors, currently recruiting.